VERU Veru Inc.
Healthcare$2.31-1.70%ClosedMarket Cap: $37.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.46
P/S
0.00
EV/EBITDA
-0.46
DCF Value
$0.66
FCF Yield
-69.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-53.4%
ROA
-32.7%
ROIC
-73.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $0.00 | NaN% | $-7.2M | $-2.7M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-5.4M | $-5.3M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-7.5M | $1.3M | $— | — |
| FY null | $0.00 | NaN% | $-24.8M | $-22.7M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-8.0M | $-7.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-8.1M | $-7.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-10.2M | $-8.9M | $— | — |
| Q4 null | $6.7M | 40.4% | $-8.2M | $-8.5M | $— | — |
| FY null | $16.9M | 34.7% | $-36.9M | $-37.8M | $— | — |
| Q3 null | $4.0M | 33.8% | $-10.9M | $-11.0M | $— | — |
| Q2 null | $4.1M | 16.4% | $-9.9M | $-10.0M | $— | — |
| Q1 2024 | $2.1M | 53.7% | $-8.8M | $-8.3M | $-0.82 | — |